Embark and Novo Nordisk enter collaboration to discover novel therapeutics for obesity and metabolic disease

_______________________________________________________________________________________

To Receive daily job alerts, Enter your email address, and dont forget to verify the job alerts:

Delivered by FeedBurner

Novo NordiskEmbark Biotech ApS and Novo Nordisk A/S have entered into a research collaboration focusing on the discovery of novel treatments for obesity and its associated metabolic pathologies through mechanisms that increase energy expenditure.